Creating cell banks for vaccine development to prepare for pandemics
Task V26: MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS
This study is working on making special cell banks to help create new vaccines that can protect people from infectious diseases, including those that might come from bioterrorism, so that we can respond quickly during health emergencies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10168829 on NIH RePORTER |
What this research studies
This research focuses on developing and manufacturing cell banks that are essential for creating vaccines against infectious diseases, including those that may arise from bioterrorism. It involves planning and optimizing vaccine production processes, ensuring compliance with regulatory standards, and conducting necessary audits. Patients may benefit from the development of new vaccines that could protect against emerging infectious diseases. The project aims to streamline the vaccine development process to ensure rapid response during health crises.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk of exposure to infectious diseases or those living in areas prone to outbreaks.
Not a fit: Patients with established immunity to specific infectious diseases or those not at risk of exposure may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the rapid development of effective vaccines for infectious diseases, enhancing public health preparedness.
How similar studies have performed: Previous research has shown success in vaccine development through similar manufacturing and characterization approaches, indicating a promising pathway for this project.
Where this research is happening
New York, United States
- International AIDS Vaccine Initiative — New York, United States (Active)
Researchers
- Principal investigator: Hassel, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassel, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.